10-K Decoder · All companies

Myriad Genetics, Inc.

MYGN · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$824M$838M−1.6%
Operating income−$387M−$124M−214%
Net income−$366M−$127M−187%

Latest quarter: Q3 2026

Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 6, 2026

$Q3 2026Year earlierChange
Revenue$203M$206M−1.5%
Operating income−$39.9M−$23.3M−71.2%
Net income−$43.9M−$27.4M−60.2%

Q3 2026 dashboardQ3 2026 infographic

Questions

What was Myriad Genetics's revenue in FY2025?
$824M in FY2025 (Fiscal year ended Dec 31, 2025), −1.6% vs $838M a year earlier, per its 10-K filed Feb 2026.
Was Myriad Genetics profitable in FY2025?
No: net income was −$366M and operating income −$387M in FY2025.
What was Myriad Genetics's revenue in Q3 2026?
$203M (−1.5% vs a year earlier), per its Form 10-Q filed Nov 6, 2026.